WHO Declares PHEIC for Ebola Outbreak in DRC & Uganda; 8 Confirmed Cases, Bundibugyo Strain Detected

EU Data Regulator Fines Google €403 Million for Location Data Violations Under GDPR

Ireland's Data Protection Commission (DPC) fined Google €403 million ($463 million) for unlawful processing of user location data. This is the fourth-largest fine by the Irish watchdog, highlighting the EU's strict enforcement of GDPR and its implications for global tech firms operating in Europe.

EU Proposes Ban on Social Media & AI Chatbots for Under-15s Under EU Kids Act

The European Commission will propose sweeping restrictions on under-15s' access to social media, AI chatbots, and online games as part of a new EU Kids Act. The proposal includes age-gated access tiers, mandatory parental controls, addiction prevention, and a supervisory fee on tech companies. This signals a major global regulatory shift on child online safety with implications for digital governance frameworks.

ISRO Launches EOS-05: India's First Geo-Imaging Satellite in Geosynchronous Orbit; SC Invokes Article 142 to Quash CJP Protest Cases

A day of high exam relevance: ISRO successfully launched EOS-05, India’s first dedicated geo-imaging satellite in geosynchronous orbit, breaking a failure streak. The Supreme Court used its extraordinary power under Article 142 to close cases linked to CJP protests, raising important constitutional questions. Other key updates include OpenAI’s new autonomous AI model, Manipur’s NRC-first demand for Census deferral, mistrust in GDP data, and Tata Chemicals’ Kenya dispute.

Meta Trial: $567 Mn Penalty for Child Addiction, 29-State Probe on Social Media Design

A US trial against Meta over addictive social media design for children could reshape Big Tech accountability. With penalties of $567 million and a $6 million jury verdict, this case highlights the growing scrutiny of platform design and its impact on youth mental health, a key issue for GS2 (Social Justice) and GS3 (Technology).

UN High-Level Meeting on Pandemic Preparedness: India Stresses Resilient Health Systems, Pathogen Access Benefit Sharing

India, represented by Union Health Secretary Punya Salila Srivastava, affirmed its commitment to global pandemic preparedness at a UN high-level meeting, emphasizing resilient health systems, digital public infrastructure, and fair access to health products. The article is crucial for aspirants as it ties India's COVID-19 experience to global health security frameworks like the WHO Pandemic Agreement and the Pathogen Access and Benefit Sharing (PABS) system.

WHO's IARC Classifies Hydrochlorothiazide, Voriconazole, Tacrolimus as Group 1 Carcinogens

Three widely used medicines for hypertension, fungal infections, and transplant rejection have been classified as Group 1 carcinogens by WHO's IARC. Patients are warned not to discontinue treatment without consulting doctors, as the classification identifies hazard, not real-world risk at prescribed doses.

IARC Classifies Three WHO Essential Medicines as Group 1 Carcinogens: Hydrochlorothiazide, Voriconazole, Tacrolimus

IARC, the WHO cancer research agency, has classified three widely used drugs—hydrochlorothiazide, voriconazole, and tacrolimus—as Group 1 carcinogens. Despite this, experts stress that patients should not stop treatment as the benefits for hypertension, fungal infections, and organ transplant rejection far outweigh the cancer risk. The drugs are on the WHO Model List of Essential Medicines and are commonly prescribed in India.

CDSCO Approves Qdenga: India's First Dengue Vaccine to be Distributed by Dr Reddy's from 2027

India’s first approved dengue vaccine Qdenga will enter the private market in 2027 via Dr Reddy’s, after CDSCO approval in July 2026. The vaccine is effective against all four serotypes, requires no pre-vaccination screening, and shows 61.2% efficacy against dengue and 84.1% against hospitalization. This is a landmark step in India's fight against dengue.